These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7146598)

  • 1. [Reclassification of multiple myeloma and calculation of the myelomatous mass as prognostic and therapeutic indications].
    Ricci C; Coscia GC; Uberti M; Discalzi G; Racca P
    Recenti Prog Med; 1982 Apr; 72(4):482-99. PubMed ID: 7146598
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy versus melphalan and prednisone in multiple myeloma.
    Gruber A; Osby E
    Chemioterapia; 1987 Jun; 6(2 Suppl):725-6. PubMed ID: 3509531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic experiences in multiple myeloma].
    Sonntag R; Favre E; Martz G
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1588-9. PubMed ID: 4566555
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple myeloma in stage I. Evaluation of the initial therapy].
    Zapatero A; Blanco L; Sevilla F; Escribano L; Odriozola J; Montalbán C
    Rev Clin Esp; 1985 May; 176(8):388-91. PubMed ID: 4023320
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemocytological classification, clinical staging and polychemotherapy of multiple myeloma].
    István L; Karl W; Michael H; Günter A; Kelényi G; Várbíró M; Dieter R
    Orv Hetil; 1983 Feb; 124(6):313-9. PubMed ID: 6835675
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
    Anderson KC; Palumbo A;
    Oncology (Williston Park); 2005 Apr; 19(4):447-50. PubMed ID: 15934516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy in osteosclerotic myeloma: clinical and electrodiagnostic improvement with chemotherapy.
    Donofrio PD; Albers JW; Greenberg HS; Mitchell BS
    Muscle Nerve; 1984 Feb; 7(2):137-41. PubMed ID: 6325905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intermittent low dose melphalan and prednisone in multiple myeloma].
    Yalon M; Levo Y; Many A; Ramot B
    Harefuah; 1977 Apr; 92(7):296-8. PubMed ID: 863310
    [No Abstract]   [Full Text] [Related]  

  • 12. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
    Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF
    Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of multiple myeloma.
    Ungaro P
    J Ky Med Assoc; 1973 Dec; 71(12):805-7. PubMed ID: 4766737
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of multiple myeloma: melphalan--40 years old and still going strong.
    Bergsagel PL
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):2-3. PubMed ID: 12533738
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple myeloma index: verification of a new prognostic approach with evaluation of treatment response.
    Bettini R; Tonolini M; Bernasconi M
    Haematologica; 1998 Aug; 83(8):708-13. PubMed ID: 9793254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)].
    Rubio Felix D; Giraldo MP; Raichs A; García Zueco JC; Mur P; Faura MV; Ruíz-Marcuello E; Piñan MA
    Sangre (Barc); 1980; 25(1):25-34. PubMed ID: 7384962
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical updates and nursing considerations for patients with multiple myeloma.
    Faiman B
    Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple myeloma and other plasma cell dyscrasias].
    del Potro Gómez E; Morales Sanz D
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():52-7. PubMed ID: 10422451
    [No Abstract]   [Full Text] [Related]  

  • 19. [Smoldering myeloma].
    Dolgos J; Patakfalvi A
    Orv Hetil; 1993 Sep; 134(39):2155-7. PubMed ID: 8414460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelomatous pleural effusion.
    Ghosh S; Gopal R; Advani SH
    J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.